Overview
Fernando Mancha practices practicing medicine in Sevilla, Spain.
His clinical expertise encompasses Stroke, Atrial Fibrillation, Carotid Artery Disease, and Stent Placement.
He is actively involved in clinical research, co-authoring 17 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Fernando Mancha
Is Fernando Mancha a top-rated expert for Stroke?
MediFind is an objective health platform that identifies experts based on real-world data. Fernando Mancha is classified as an Experienced expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fernando Mancha participate in research or clinical trials?
Yes. Fernando Mancha has published 17 articles and abstracts on conditions like Stroke. You can view a list of Fernando Mancha's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Atrial FibrillationMr. Mancha isExperienced. Learn about Atrial Fibrillation.
- Carotid Artery DiseaseMr. Mancha isExperienced. Learn about Carotid Artery Disease.
- Stent PlacementMr. Mancha isExperienced. Learn about Stent Placement.
- StrokeMr. Mancha isExperienced. Learn about Stroke.